| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/27/2011 | CN102028729A Method for simultaneously extracting caulis trachelospermi total lignan and total flavone |
| 04/27/2011 | CN102028727A Chinese patent medicine for treating colon cancer and preparation method thereof |
| 04/27/2011 | CN102028722A Extract of effective parts of total saponins in pterocephalus hookeri as well as preparation method and application thereof |
| 04/27/2011 | CN102028720A Composition for treating leukemia |
| 04/27/2011 | CN102028712A Method for preparing enteric capsules by taking leech as raw material |
| 04/27/2011 | CN102028710A Method for measuring contents of indole alkaloids in cinobufagin alcohol precipitation liquid |
| 04/27/2011 | CN102028706A Flushing liquid for liver-cancer surgical incisions |
| 04/27/2011 | CN102028698A Medicine for treating colon cancer and preparation method thereof |
| 04/27/2011 | CN102028689A Compound medicinal composition for treating acute lymphocytic leukemia |
| 04/27/2011 | CN102028685A Application of Gimeracil |
| 04/27/2011 | CN102028679A Vitexicarpin as drug active ingredient with anti-angiogenic effect |
| 04/27/2011 | CN102028678A Application of salvianolic acid A in preparing anti-tumor metastasis medicine |
| 04/27/2011 | CN102028657A Solid preparation of acetylcysteine liposome |
| 04/27/2011 | CN102028308A Anticancer fragrance-increasing cigarette holder |
| 04/27/2011 | CN101711756B Application of 3-phenyl-3-(4-nitryl phenylamino)-1-(4-chlorphenyl)-1-acetone as non-steroidal androgen receptor regulating agent |
| 04/27/2011 | CN101698038B Paster for treating cancer pain and preparation method thereof |
| 04/27/2011 | CN101632641B Lentinan lyophilized power injection and preparation method thereof |
| 04/27/2011 | CN101632637B Polyene taxol lipid preparation and method for preparing same |
| 04/27/2011 | CN101580821B 2-naphthoic monooxygenase for preparing anti-cancer medicament indigo red |
| 04/27/2011 | CN101530432B Method for producing degreased concentrated solution of tussah male moth |
| 04/27/2011 | CN101492455B Optical pure levorotation cephalotaxine and separation purification method |
| 04/27/2011 | CN101474151B Alkannin microemulsion composition |
| 04/27/2011 | CN101463131B Gamma-polyglutamic acid-asparaginic acid polymer and its complex, and preparation and use thereof |
| 04/27/2011 | CN101434629B SiRNA sequence inhibiting human Akt2 gene expression and fusion expression vector |
| 04/27/2011 | CN101428003B Preparation of RGDF-fatty alcohol couplet mediated adriablastina target lipid and uses as anti-tumour agents |
| 04/27/2011 | CN101411744B Medicament for treating neoplastic disease |
| 04/27/2011 | CN101406566B Chinese medicine for treating gastric cancer |
| 04/27/2011 | CN101406513B Malaytea scurfpea fruit extract, pharmaceutical composition containing the same, and preparation method and application thereof |
| 04/27/2011 | CN101401891B Traditional Chinese medicine decoction for treating aplastic anemia |
| 04/27/2011 | CN101396351B Drug-loaded polyelectrolyte capsules in response to phosphatase concentration and preparation method thereof |
| 04/27/2011 | CN101327328B Dendrimers targeting nano particle and preparation and application thereof |
| 04/27/2011 | CN101327190B Anti-tumor long-circulating target liposomes for injections |
| 04/27/2011 | CN101318980B Dicaryon platinum containing complex, preparation method and application thereof |
| 04/27/2011 | CN101288642B Taxanes medicine preparation for intravenous injection and preparation method thereof |
| 04/27/2011 | CN101265284B Method for synthesizing clofarabine |
| 04/27/2011 | CN101260157B Fusion polypeptide and application thereof in preparing antineoplastic, antiviral and intracellular bacterial parasite infection curing medicament |
| 04/27/2011 | CN101255418B Human heparinase RNA interference target sequence and uses thereof |
| 04/27/2011 | CN101234191B Use of human recombination hepatic stimulator substance for reinforcing anti-apoptosis of liver cancer cell and application thereof |
| 04/27/2011 | CN101220008B Synthesis of compound ABT-263 |
| 04/27/2011 | CN101172994B Small disturbance RNA of interleukin 17 acceptor mIL-17RE gene, encoding gene and application of the same |
| 04/27/2011 | CN101134057B Compound medicament of natural plant extract containing paclitaxel and anticancer application thereof |
| 04/27/2011 | CN101132798B Application of nucleic acid molecule in preparing medicine for treatment of neoplasms and composition |
| 04/27/2011 | CN101092417B Folacin analogue, and salt of folacin analogue in use for medical treatment |
| 04/27/2011 | CN101062094B Total salvianolic acids long-cycle liposomes and the preparing method thereof |
| 04/27/2011 | CN101033224B Novel pyrimidines small molecular compound, its preparation method and use |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | US7932384 Reverse-turn mimetics and method relating thereto |
| 04/26/2011 | US7932382 Amide substituted heterocylic compound; anticarcinogen; inducing apoptotic cell death, sensitizing cells to inducers of apoptosis |
| 04/26/2011 | US7932367 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932281 Amine-based compound and use thereof |
| 04/26/2011 | US7932257 Substituted pyrazolo[4,3-d]pyrimidines as aurora kinase inhibitors |
| 04/26/2011 | US7932234 Bispecific oligonucleotide for the treatment of CNS malignancies |
| 04/26/2011 | US7931903 Internalizing anti-CD74 antibodies and methods of use |
| 04/26/2011 | US7931897 Therapeutic agent for hematopoietic tumors |
| 04/26/2011 | US7931895 Monoclonal antibodies with enhanced ADCC function |
| 04/26/2011 | US7931022 Method and apparatus for dispensing inhalator medicament |
| 04/26/2011 | CA2479133C 2-4-diaminopyrimidine derivatives |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/26/2011 | CA2471059C Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 04/26/2011 | CA2467718C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/26/2011 | CA2462657C Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 04/26/2011 | CA2460145C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 04/26/2011 | CA2447999C Caspase inhibitors and uses thereof |
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2446112C A method for regulating immune function in primates using the foxp3 protein |
| 04/26/2011 | CA2439337C Highly sulfated derivatives of k5 polysaccharide and their preparation |
| 04/26/2011 | CA2423628C Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/26/2011 | CA2416572C Bispecific antibody for target cell-specific stimulation of the apo-1 cell surface receptor |
| 04/26/2011 | CA2415397C Use of strains of parapoxvirus ovis for producing antiviral medicaments and medicaments against cancer |
| 04/26/2011 | CA2388656C Use of biodegradable microspheres that release an anticancer agent for treating gliobastoma |
| 04/26/2011 | CA2353554C Palladium-substituted bacteriochlorophyll derivatives and use thereof |
| 04/26/2011 | CA2319093C Sea cucumber carotenoid lipid fraction products and methods of use |
| 04/26/2011 | CA2264012C Compositions and methods for polynucleotide delivery |
| 04/21/2011 | WO2011047384A2 Methods of inhibiting ire1 |
| 04/21/2011 | WO2011047277A2 Release of agents from cells |
| 04/21/2011 | WO2011047269A2 Elongator proteins and use thereof as dna demethylases |
| 04/21/2011 | WO2011047262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | WO2011047195A1 Treating neurotoxicity associated with combinations of 5 - fu or its prodrugs and dpd inhibitors |
| 04/21/2011 | WO2011047180A1 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof |
| 04/21/2011 | WO2011047173A2 Pharmaceutical compositions for oral administration |
| 04/21/2011 | WO2011047135A2 Compositions and methods for treating bladder cancer |
| 04/21/2011 | WO2011047097A2 Inhibition of trem receptor signaling with peptide variants |
| 04/21/2011 | WO2011047055A2 Novel mek inhibitors, useful in the treatment of diseases |
| 04/21/2011 | WO2011047051A2 Polymeric systems for the delivery of anticancer agents |
| 04/21/2011 | WO2011046991A2 Certain substituted ureas as modulators of kinase activity |
| 04/21/2011 | WO2011046958A1 Use of il-17 receptor a antigen binding proteins |
| 04/21/2011 | WO2011046922A1 Use of nibp polypeptides |
| 04/21/2011 | WO2011046832A2 Granulysin in immunotherapy |
| 04/21/2011 | WO2011046599A2 Treatment and prognosis with thalidomide in multiple myeloma based on karyotyping and gene expression profiling |
| 04/21/2011 | WO2011046596A2 Anti-cancer tamoxifen-melatonin hybrid ligand |
| 04/21/2011 | WO2011046515A1 Antiproliferative agent |
| 04/21/2011 | WO2011046457A1 Anti-neoplastic uses of artemin antagonists |
| 04/21/2011 | WO2011046382A2 Nrf2 inhibitors and use thereof |
| 04/21/2011 | WO2011046381A2 COMPOSITION FOR INHIBITING TGF-β COMPRISING IMIDAZOPURINE DERIVATIVES |
| 04/21/2011 | WO2011046221A1 INTERFERON-α MODULATOR |
| 04/21/2011 | WO2011046200A1 Antiinflammatory agent comprising differentiation-inducing factor or analog thereof |
| 04/21/2011 | WO2011045704A1 Cancer treatment |
| 04/21/2011 | WO2011045646A1 Imidazothiazole-chalcone derivatives as potential anticancer agents and process for the preparation thereof |
| 04/21/2011 | WO2011045344A1 Pyrazolopyridine derivatives as anticancer agent |